Biguanide
Pregnancy: B — used in gestational diabetes in some guidelines
Metformin
Brand names: Glucophage, Metabet
Adult dose
Dose: 500mg–1g twice daily
Route: Oral
Frequency: Twice daily with meals
Start 500mg OD/BD with food. Titrate monthly. Max 2g/day in divided doses. Modified-release: 500mg–2g once daily with evening meal.
Clinical pearls
- First-line oral agent in T2DM regardless of HbA1c (unless contraindicated)
- Weight-neutral or slight weight loss — advantage over sulfonylureas
- Check B12 annually after 4+ years of use — causes B12 malabsorption
- Modified-release formulation better tolerated GI-wise
- Hold perioperatively and during acute illness (dehydration risk)
Contraindications
- eGFR <30 mL/min/1.73m²
- Acute kidney injury
- Hepatic failure
- Contrast media (hold 48h before/after)
- Acute illness with dehydration
Side effects
- GI upset (nausea, diarrhoea — dose-related)
- Vitamin B12 deficiency (long-term)
- Lactic acidosis (rare, usually with contraindications)
- Metallic taste
Interactions
- Iodinated contrast — hold for 48h post-contrast in eGFR <60
- Alcohol — increased lactic acidosis risk
Monitoring
- HbA1c (every 3 months until stable, then 6-monthly)
- eGFR annually
- Vitamin B12 annually
Reference: NICE NG28; ADA Standards of Care 2025. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016